This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Xenia Hotels & Resorts (XHR) Tops Q2 FFO and Revenue Estimates
by Zacks Equity Research
Xenia Hotels & Resorts (XHR) delivered FFO and revenue surprises of +32.56% and +5.23%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
STRW or NHI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
STRW vs. NHI: Which Stock Is the Better Value Option?
National Health Investors (NHI) Q1 FFO and Revenues Beat Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered FFO and revenue surprises of 1.77% and 0.52%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Centerspace (CSR) Matches Q1 FFO Estimates
by Zacks Equity Research
Centerspace (CSR) delivered FFO and revenue surprises of 0% and 0.59%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
CUZ vs. NHI: Which Stock Is the Better Value Option?
by Zacks Equity Research
CUZ vs. NHI: Which Stock Is the Better Value Option?
Bank of Marin (BMRC) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Bank of Marin (BMRC) delivered earnings and revenue surprises of -6.25% and 0.84%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
CUZ or NHI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CUZ vs. NHI: Which Stock Is the Better Value Option?
Welltower Secures Credit Rating Upgrade From S&P & Moody's
by Zacks Equity Research
In a positive development, WELL achieves an 'A-' credit rating from S&P and an 'A3' credit rating from Moody's, based on its operational excellence and balance sheet strength.
INN or NHI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
INN vs. NHI: Which Stock Is the Better Value Option?
National Health Investors (NHI) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for National Health Investors (NHI) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
National Health Investors (NHI) Tops Q4 FFO and Revenue Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered FFO and revenue surprises of 2.73% and 2.52%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
STRW vs. NHI: Which Stock Is the Better Value Option?
by Zacks Equity Research
STRW vs. NHI: Which Stock Is the Better Value Option?
Innovative Industrial Properties (IIPR) Matches Q4 FFO Estimates
by Zacks Equity Research
Innovative Industrial Properties (IIPR) delivered FFO and revenue surprises of 0% and 0.09%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Digital Realty Trust (DLR) Tops Q4 FFO Estimates
by Zacks Equity Research
Digital Realty Trust (DLR) delivered FFO and revenue surprises of 1.76% and 1.47%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
PSTL vs. NHI: Which Stock Is the Better Value Option?
by Zacks Equity Research
PSTL vs. NHI: Which Stock Is the Better Value Option?
RLJ vs. NHI: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
RLJ vs. NHI: Which Stock Is the Better Value Option?
CHCT or NHI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CHCT vs. NHI: Which Stock Is the Better Value Option?
CHCT vs. NHI: Which Stock Is the Better Value Option?
by Zacks Equity Research
CHCT vs. NHI: Which Stock Is the Better Value Option?
Is Global X SuperDividend U.S. ETF (DIV) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DIV
National Health Investors (NHI) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for National Health Investors (NHI) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
National Health Investors (NHI) Q3 FFO Miss Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered FFO and revenue surprises of -3.74% and 2.78%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Ryman Hospitality Properties (RHP) Q3 FFO and Revenues Surpass Estimates
by Zacks Equity Research
Ryman Hospitality Properties (RHP) delivered FFO and revenue surprises of 9.04% and 0.88%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Employers Holdings (EIG) Beats Q3 Earnings Estimates
by Zacks Equity Research
Employers Holdings (EIG) delivered earnings and revenue surprises of 3.85% and 0.53%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Park Hotels & Resorts (PK) Matches Q3 FFO Estimates
by Zacks Equity Research
Park Hotels & Resorts (PK) delivered FFO and revenue surprises of 0% and 0.91%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
PLYM or NHI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PLYM vs. NHI: Which Stock Is the Better Value Option?